Baculovirus-based vaccines
AssigneesKonkuk University Industrial Cooperation Corp., KR Biotech Co., Ltd.
InventorsYoung-Bong KIM, Hee Jung Lee, Nuri Park, Yu-Kyoung Oh
Life of this patent
Estimating the term…
Loading patent…
AssigneesKonkuk University Industrial Cooperation Corp., KR Biotech Co., Ltd.
InventorsYoung-Bong KIM, Hee Jung Lee, Nuri Park, Yu-Kyoung Oh
Estimating the term…
The present invention relates to a recombinant baculovirus comprising: (a) a nucleotide sequence encoding a foreign virus envelope protein; (b) a first promoter operatively linked to the envelope-encoding nucleotide sequence; (c) a nucleotide sequence encoding an antigen protein; and (d) a second promoter operatively linked to the antigen-encoding nucleotide sequence; and a vaccine composition using the same. The recombinant baculovirus of the present invention has an excellent efficacy on both humoral and cellular immune responses against a specific antigen (e.g., HPV L1), enabling to function as a more efficient DNA vaccine.
1-19. (canceled)
A method for inducing an immune response against a specific antigen in a mammalian subject in need thereof, comprising:
Dependencies are inferred from the claim text.